It was shown that resveratrol significantly attenuates the visfatin effect on reducing the cytotoxicity of capecitabine in human DLD-1 CRC cells in a dose-dependent manner, which resulted in a recovery in the visfatin-increased cell viability (Figure 5A) and decreased cell death (Figure 5B). Here, NAMPT is linked to colorectal carcinoma.